Akebia therapeutics, inc. AKBA.US AI Analysis
BetaUS StockHealthcare
(No presentation for AKBA)
AKBA Value Score
3
24
15
Good Growth
Analysis Conclusion
The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
AKBA Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of AKBA from 2014-03-20 till Now
- -15.40%
- Cumulative Return
- -1.48%
- Annual Return
- 57.41%
- Volatility
- -0.03
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from March, 2014 to June, 2025. (Total Trades: 2)
| AKBA | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 50% | 46% | 55% |
| Avg Return | -7.9% | 46.2% | 58.8% |
| Avg Profit | 13.2% | 148.3% | 131.8% |
| Avg Loss | -29.1% | -39.9% | -31.2% |
| Avg Risk-Reward Ratio | 45.5% | 371.3% | 422.8% |